Lesson 1High-intensity statin initiation: timin', expected benefits, monitorin' fi adverse effectsExplains when an' how to start high-intensity statins in suspected ACS, expected plaque-stabilizin' benefits, baseline labs, monitorin' fi myopathy or liver injury, an' counselin' to support long-term adherence.
Timin' a statin start in ACS pathwayChoosin' appropriate statin an' doseBaseline liver an' muscle assessmentsMonitorin' fi myopathy an' hepatotoxicityPatient counselin' an' adherence supportLesson 2Oxygen therapy: evidence-based thresholds fi use, titration to target SpO2, risks a hyperoxiaExamines oxygen therapy in suspected ACS, emphasizin' evidence-based thresholds fi initiation, titration to target oxygen saturation, avoidance a hyperoxia, an' documentation a indications an' patient response.
When to start oxygen in suspected ACSTarget SpO2 ranges an' titration stepsRisks an' mechanisms a hyperoxia harmDevice selection an' flow adjustmentsMonitorin' an' documentin' oxygen responseLesson 3Nitroglycerin: sublingual administration steps, hemodynamic checks, contraindications (PDE-5 inhibitors), management a hypotensionOutlines safe nitroglycerin use, includin' sublingual administration steps, pre- an' post-dose hemodynamic checks, contraindications such as PDE-5 inhibitors, an' management strategies fi nitro-induced hypotension.
Sublingual nitroglycerin administration stepsPre-dose blood pressure an' pain checksScreenin' fi PDE-5 inhibitor useRecognizin' nitroglycerin side effectsManagin' an' documentin' hypotensionLesson 4Aspirin: dosin', mechanism in ACS, contraindications, assessment before an' after administrationProvides a focused review a aspirin use in ACS, includin' loadin' an' maintenance doses, antiplatelet mechanism, contraindications, an' structured assessments before an' after administration fi safety an' efficacy.
Aspirin loadin' an' maintenance dosin'Mechanism a platelet inhibition in ACSContraindications an' relative cautionsPre-dose assessment an' risk screenin'Post-dose monitorin' an' reassessmentLesson 5Medication interaction an' allergy checks: cross-checkin' home meds, diabetes an' beta-blocker interactions, renal dosin' considerationsFocuses pon systematically identifyin' allergies, prior adverse reactions, an' high-risk drug interactions, includin' diabetes therapies, beta-blockers, an' renally cleared drugs, to prevent avoidable harm in ACS patients.
Structured allergy an' reaction historyCross-checkin' home an' inpatient medsDiabetes drugs an' beta-blocker maskin'Renal dosin' an' nephrotoxic combinationsUsin' EHR alerts an' pharmacist supportLesson 6Overview a ACS pharmacotherapy: antiplatelets, anticoagulants, nitrates, beta-blockers, statins, oxygen rationaleReviews core ACS medications, dem mechanisms, indications, an' contraindications, wid emphasis pon initial selection, sequencin', an' bedside safety checks to balance ischemia relief wid bleedin' an' hemodynamic risks.
Roles a antiplatelet agents in ACSAnticoagulant options an' selectionUse a nitrates fi ischemic chest painEarly beta-blocker therapy considerationsHigh-intensity statins in ACS careOxygen use an' current ACS evidenceLesson 7Anticoagulation wid enoxaparin: dosin' based pon weight/renal function, timin' relative to procedures, bleedin' risk assessment an' monitorin'Covers enoxaparin use fi ACS anticoagulation, includin' weight an' renal-based dosin', timin' around invasive procedures, bleedin' risk assessment, monitorin' strategies, an' coordination wid di cardiology team.
Weight-based dosin' calculationsRenal impairment dose adjustmentsTimin' wid PCI an' other proceduresBaseline an' ongoin' bleedin' assessmentMonitorin' anti-Xa an' lab parametersReversal an' management a major bleedin'Lesson 8Beta-blockers (metoprolol): indications, IV vs PO use, blood pressure an' heart rate criteria, dose titration an' monitorin' fi bradycardiaReviews metoprolol use in ACS, includin' indications, choosin' IV versus oral routes, blood pressure an' heart rate criteria, titration strategies, an' monitorin' fi bradycardia, hypotension, an' bronchospasm.
Indications an' contraindications in ACSIV versus oral metoprolol selectionBlood pressure an' heart rate thresholdsDose titration an' reassessmentMonitorin' fi bradycardia an' hypotensionLesson 9Documentation an' communication wid di provider bout medication responses an' lab-guided adjustmentsDetails best practices fi documentin' medication indications, responses, an' adverse events, an' fi communicatin' wid providers to guide lab-based dose adjustments an' therapy escalation or de-escalation.
Recordin' indications an' time a dosin'Chartin' responses an' side effectsCommunicatin' critical changes promptlyUsin' labs to guide dose adjustmentsHandoff reports an' interdisciplinary notesLesson 10Monitorin' fi adverse effects: hypotension, bradycardia, bleedin', allergic reactions, an' stepwise response algorithmsCovers early recognition an' management a hypotension, bradycardia, bleedin', an' allergic reactions after ACS medications, usin' stepwise algorithms, escalation triggers, an' documentation a response to interventions.
Vital sign an' perfusion surveillanceBleedin' risk signs an' bedside checksRecognition a drug-induced bradycardiaIdentifyin' an' treatin' allergic reactionsStepwise response an' escalation pathwaysPost-event reassessment an' documentation